Aamir Dam
Papers
1
Total Citations
2
H-Index
1
About
Dr. Aamir Dam is a rising clinician-investigator specializing in the management of mismatch repair-deficient (dMMR) gastroesophageal junction (GEJ) cancers, a subset of tumors highly responsive to immunotherapy. His most cited work, a 2023 case report on a 70-year-old patient with locally advanced dMMR GEJ cancer, demonstrates his focus on precision oncology in older, comorbid populations. The paper details a comprehensive approach to diagnosis, treatment modifications, and monitoring, highlighting how immune checkpoint inhibitors can be effectively integrated into care for patients with complex medical histories—including asthma, hypertension, and sleep apnea—who often face treatment disparities. While his citation count is early in his career, this foundational work underscores his contribution to personalizing therapy for rare, molecularly defined tumors. Dr. Dam’s research bridges the gap between molecular pathology and real-world clinical decision-making, offering a template for managing dMMR GEJ cancers in vulnerable patients. His growing expertise positions him as a key voice in expanding access to immunotherapy for traditionally underrepresented populations in oncology trials.
Research Focus
Key Achievements
Top Papers
- 1